Protagonist Therapeutics, Inc Weighted Average Number of Shares Outstanding, Basic and Diluted
Protagonist Therapeutics, Inc (PTGX) reported Weighted Average Number of Shares Outstanding, Basic and Diluted of 49.05 million shares for the 3-month period ending 2022-06-30, per its 10-Q filed 2022-08-04.
Discontinued › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted · last filed 2022-08-04
- Protagonist Therapeutics, Inc weighted average number of shares outstanding, basic and diluted for the quarter ending 2022-06-30 was 49.05M shares, a 9.33% increase year-over-year.
- Protagonist Therapeutics, Inc weighted average number of shares outstanding, basic and diluted for the quarter ending 2022-03-31 was 48.75M shares, a 10.24% increase year-over-year.
- Protagonist Therapeutics, Inc weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-12-31 was 48.17M shares, a 21.52% increase year-over-year.
- Protagonist Therapeutics, Inc weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-09-30 was 47.99M shares, a 28.35% increase year-over-year.
- Protagonist Therapeutics, Inc weighted average number of shares outstanding, basic and diluted for fiscal 2021 was 46.32M shares, a 34.67% increase from fiscal 2020.
- Protagonist Therapeutics, Inc weighted average number of shares outstanding, basic and diluted for fiscal 2020 was 34.40M shares, a 32.84% increase from fiscal 2019.
- Protagonist Therapeutics, Inc weighted average number of shares outstanding, basic and diluted for fiscal 2019 was 25.89M shares, a 15.78% increase from fiscal 2018.
- Protagonist Therapeutics, Inc weighted average number of shares outstanding, basic and diluted for fiscal 2018 was 22.36M shares, a 26.39% increase from fiscal 2017.
| Period end | Weighted Average Number of Shares Outstanding, Basic and Diluted 3 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 6 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 9 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 12 month |
|---|---|---|---|---|
| 2022-06-30 | 49.05M shares 10-Q · filed 2022-08-04 | 48.90M shares 10-Q · filed 2022-08-04 | 48.66M shares derived: average of 3 quarters · filed 2022-08-04 | 48.49M shares derived: average of 4 quarters · filed 2022-08-04 |
| 2022-03-31 | 48.75M shares 10-Q · filed 2022-05-05 | 48.46M shares derived: average of 2 quarters · filed 2022-05-05 | 48.30M shares derived: average of 3 quarters · filed 2022-05-05 | 47.44M shares derived: average of 4 quarters · filed 2022-08-04 |
| 2021-12-31 | 48.17M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | 48.08M shares derived: average of 2 quarters · filed 2022-02-28 | 47.01M shares derived: average of 3 quarters · filed 2022-08-04 | 46.32M shares 10-K · filed 2022-02-28 |
| 2021-09-30 | 47.99M shares 10-Q · filed 2021-11-03 | 46.43M shares derived: average of 2 quarters · filed 2022-08-04 | 45.71M shares 10-Q · filed 2021-11-03 | 44.18M shares derived: average of 4 quarters · filed 2022-08-04 |
| 2021-06-30 | 44.86M shares 10-Q · filed 2022-08-04 | 44.55M shares 10-Q · filed 2022-08-04 | 42.91M shares derived: average of 3 quarters · filed 2022-08-04 | 41.53M shares derived: average of 4 quarters · filed 2022-08-04 |
| 2021-03-31 | 44.22M shares 10-Q · filed 2022-05-05 | 41.93M shares derived: average of 2 quarters · filed 2022-05-05 | 40.42M shares derived: average of 3 quarters · filed 2022-05-05 | 38.51M shares derived: average of 4 quarters · filed 2022-05-05 |
| 2020-12-31 | 39.64M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | 38.52M shares derived: average of 2 quarters · filed 2022-02-28 | 36.61M shares derived: average of 3 quarters · filed 2022-02-28 | 34.40M shares 10-K · filed 2022-02-28 |
| 2020-09-30 | 37.39M shares 10-Q · filed 2021-11-03 | 35.09M shares derived: average of 2 quarters · filed 2021-11-03 | 32.65M shares 10-Q · filed 2021-11-03 | 31.38M shares derived: average of 4 quarters · filed 2022-02-28 |
| 2020-06-30 | 32.80M shares 10-Q · filed 2021-08-04 | 30.25M shares 10-Q · filed 2021-08-04 | 29.38M shares derived: average of 3 quarters · filed 2022-02-28 | 28.77M shares derived: average of 4 quarters · filed 2022-02-28 |
| 2020-03-31 | 27.70M shares 10-Q · filed 2021-05-04 | 27.67M shares derived: average of 2 quarters · filed 2022-02-28 | 27.43M shares derived: average of 3 quarters · filed 2022-02-28 | 26.74M shares derived: average of 4 quarters · filed 2022-02-28 |
| 2019-12-31 | 27.63M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | 27.29M shares derived: average of 2 quarters · filed 2022-02-28 | 26.42M shares derived: average of 3 quarters · filed 2022-02-28 | 25.89M shares 10-K · filed 2022-02-28 |
| 2019-09-30 | 26.96M shares 10-Q · filed 2020-11-04 | 25.81M shares derived: average of 2 quarters · filed 2020-11-04 | 25.32M shares 10-Q · filed 2020-11-04 | 25.03M shares derived: average of 4 quarters · filed 2021-03-10 |
| 2019-06-30 | 24.66M shares 10-Q · filed 2020-08-06 | 24.48M shares 10-Q · filed 2020-08-06 | 24.39M shares derived: average of 3 quarters · filed 2021-03-10 | 24.02M shares derived: average of 4 quarters · filed 2021-03-10 |
| 2019-03-31 | 24.30M shares 10-Q · filed 2020-05-07 | 24.25M shares derived: average of 2 quarters · filed 2021-03-10 | 23.81M shares derived: average of 3 quarters · filed 2021-03-10 | 23.16M shares derived: average of 4 quarters · filed 2021-03-10 |
| 2018-12-31 | 24.21M shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-10 | 23.56M shares derived: average of 2 quarters · filed 2021-03-10 | 22.78M shares derived: average of 3 quarters · filed 2021-03-10 | 22.36M shares 10-K · filed 2021-03-10 |
| 2018-09-30 | 22.91M shares 10-Q · filed 2019-11-06 | 22.06M shares derived: average of 2 quarters · filed 2019-11-06 | 21.75M shares 10-Q · filed 2019-11-06 | 21.36M shares derived: average of 4 quarters · filed 2020-03-10 |
| 2018-06-30 | 21.21M shares 10-Q · filed 2019-08-07 | 21.16M shares 10-Q · filed 2019-08-07 | 20.85M shares derived: average of 3 quarters · filed 2020-03-10 | 19.86M shares derived: average of 4 quarters · filed 2020-03-10 |
| 2018-03-31 | 21.11M shares 10-Q · filed 2019-05-08 | 20.67M shares derived: average of 2 quarters · filed 2020-03-10 | 19.42M shares derived: average of 3 quarters · filed 2020-03-10 | 18.78M shares derived: average of 4 quarters · filed 2020-03-10 |
| 2017-12-31 | 20.22M shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-10 | 18.57M shares derived: average of 2 quarters · filed 2020-03-10 | 18.00M shares derived: average of 3 quarters · filed 2020-03-10 | 17.69M shares 10-K · filed 2020-03-10 |
| 2017-09-30 | 16.91M shares 10-Q · filed 2018-11-06 | 16.89M shares derived: average of 2 quarters · filed 2018-11-06 | 16.85M shares 10-Q · filed 2018-11-06 | 16.84M shares derived: average of 4 quarters · filed 2019-03-12 |
| 2017-06-30 | 16.88M shares 10-Q · filed 2018-08-07 | 16.82M shares 10-Q · filed 2018-08-07 | 16.81M shares derived: average of 3 quarters · filed 2019-03-12 | 14.73M shares derived: average of 4 quarters · filed 2019-03-12 |
| 2017-03-31 | 16.77M shares 10-Q · filed 2018-05-09 | 16.78M shares derived: average of 2 quarters · filed 2019-03-12 | 14.01M shares derived: average of 3 quarters · filed 2019-03-12 | 10.61M shares derived: average of 4 quarters · filed 2019-03-12 |
| 2016-12-31 | 16.79M shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-12 | 12.64M shares derived: average of 2 quarters · filed 2019-03-12 | 8.55M shares derived: average of 3 quarters · filed 2019-03-12 | 6.50M shares 10-K · filed 2019-03-12 |
| 2016-09-30 | 8.48M shares 10-Q · filed 2017-11-07 | 4.43M shares derived: average of 2 quarters · filed 2017-11-07 | 3.07M shares 10-Q · filed 2017-11-07 | 2.36M shares derived: average of 4 quarters · filed 2018-03-07 |
| 2016-06-30 | 383.91K shares 10-Q · filed 2017-08-08 | 335.86K shares 10-Q · filed 2017-08-08 | 314.23K shares derived: average of 3 quarters · filed 2018-03-07 | 303.77K shares derived: average of 4 quarters · filed 2018-03-07 |
| 2016-03-31 | 287.80K shares 10-Q · filed 2017-05-10 | 279.39K shares derived: average of 2 quarters · filed 2018-03-07 | 277.06K shares derived: average of 3 quarters · filed 2018-03-07 | 266.18K shares derived: average of 4 quarters · filed 2018-03-07 |
| 2015-12-31 | 270.97K shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-07 | 271.69K shares derived: average of 2 quarters · filed 2018-03-07 | 258.97K shares derived: average of 3 quarters · filed 2018-03-07 | 251.72K shares 10-K · filed 2018-03-07 |
| 2015-09-30 | 272.41K shares 10-Q · filed 2016-11-14 | 252.97K shares derived: average of 2 quarters · filed 2016-11-14 | 245.30K shares 10-Q · filed 2016-11-14 | |
| 2015-06-30 | 233.53K shares 10-Q · filed 2016-09-15 | 231.52K shares 10-Q · filed 2016-09-15 | ||
| 2014-12-31 | 227.20K shares 10-K · filed 2017-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |